These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 9833072)
41. Characterization of complex chromosomal abnormalities in uveal melanoma by fluorescence in situ hybridization, spectral karyotyping, and comparative genomic hybridization. Naus NC; van Drunen E; de Klein A; Luyten GP; Paridaens DA; Alers JC; Ksander BR; Beverloo HB; Slater RM Genes Chromosomes Cancer; 2001 Mar; 30(3):267-73. PubMed ID: 11170284 [TBL] [Abstract][Full Text] [Related]
42. [Meningioma: a model of cytogenetic evolution in tumoral initiation and progresion]. López-Ginés C; Gil-Benso R; Collado-Díaz M; Gregori-Romero M; Roldán P; Barberá J; Cerdá-Nicolás M Neurocirugia (Astur); 2003 Dec; 14(6):517-25. PubMed ID: 14710307 [TBL] [Abstract][Full Text] [Related]
43. A role for telomeric and centromeric instability in the progression of chromosome aberrations in meningioma patients. Sawyer JR; Husain M; Pravdenkova S; Krisht A; Al-Mefty O Cancer; 2000 Jan; 88(2):440-53. PubMed ID: 10640979 [TBL] [Abstract][Full Text] [Related]
47. [Cytogenetic patterns in Warthin tumor]. Russo C; Brunelli M; Baroli P Acta Otorhinolaryngol Ital; 1993; 13(6):551-8. PubMed ID: 8209693 [TBL] [Abstract][Full Text] [Related]
48. Delineation of commonly deleted chromosomal regions in meningiomas by high-density single nucleotide polymorphism genotyping arrays. Tabernero MD; Maíllo A; Nieto AB; Diez-Tascón C; Lara M; Sousa P; Otero A; Castrillo A; Patino-Alonso Mdel C; Espinosa A; Mackintosh C; de Alava E; Orfao A Genes Chromosomes Cancer; 2012 Jun; 51(6):606-17. PubMed ID: 22371336 [TBL] [Abstract][Full Text] [Related]
49. Genetic characterization of Sézary's syndrome by conventional cytogenetics and cross-species color banding fluorescent in situhybridization. Espinet B; Salido M; Pujol RM; Florensa L; Gallardo F; Domingo A; Servitje O; Estrach T; Garcìa-Muret P; Woessner S; Serrano S; Solé F Haematologica; 2004 Feb; 89(2):165-73. PubMed ID: 15003891 [TBL] [Abstract][Full Text] [Related]
50. A comparison of the cell lines used in meningioma research. Ragel BT; Couldwell WT; Gillespie DL; Wendland MM; Whang K; Jensen RL Surg Neurol; 2008 Sep; 70(3):295-307; discussion 307. PubMed ID: 18261772 [TBL] [Abstract][Full Text] [Related]
51. Altered expression of beta-catenin/E-cadherin in meningiomas. Brunner EC; Romeike BF; Jung M; Comtesse N; Meese E Histopathology; 2006 Aug; 49(2):178-87. PubMed ID: 16879395 [TBL] [Abstract][Full Text] [Related]
52. Correlation between cytogenetic and histopathological findings in 65 human meningiomas. Casalone R; Simi P; Granata P; Minelli E; Giudici A; Butti G; Solero CL Cancer Genet Cytogenet; 1990 Apr; 45(2):237-43. PubMed ID: 2317772 [TBL] [Abstract][Full Text] [Related]
53. Interphase cytogenetics: a new tool for the study of genetic changes in brain tumors. Arnoldus EP; Wolters LB; Voormolen JH; van Duinen SG; Raap AK; van der Ploeg M; Peters AC J Neurosurg; 1992 Jun; 76(6):997-1003. PubMed ID: 1588436 [TBL] [Abstract][Full Text] [Related]
54. Predictive value of progression-associated chromosomal aberrations for the prognosis of meningiomas: a retrospective study of 198 cases. Ketter R; Henn W; Niedermayer I; Steilen-Gimbel H; König J; Zang KD; Steudel WI J Neurosurg; 2001 Oct; 95(4):601-7. PubMed ID: 11596954 [TBL] [Abstract][Full Text] [Related]
55. Biologic heterogeneity of angiomatous meningiomas. Janowska K; Kordek R; Biernat W; Liberski PP; Krul W; Debiec-Rychter M Pol J Pathol; 1998; 49(4):279-84. PubMed ID: 10323082 [TBL] [Abstract][Full Text] [Related]
56. Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group. Mertens F; Dal Cin P; De Wever I; Fletcher CD; Mandahl N; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; van Den Berghe H; Vanni R; Willén H J Pathol; 2000 Jan; 190(1):31-8. PubMed ID: 10640989 [TBL] [Abstract][Full Text] [Related]
57. Loss of chromosomes 22 and 14 in the malignant progression of meningiomas. A comparative study of fluorescence in situ hybridization (FISH) and standard cytogenetic analysis. Schneider BF; Shashi V; von Kap-herr C; Golden WL Cancer Genet Cytogenet; 1995 Dec; 85(2):101-4. PubMed ID: 8548731 [TBL] [Abstract][Full Text] [Related]
58. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH. Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786 [TBL] [Abstract][Full Text] [Related]
59. Fluorescent in situ hybridization 1p/19q deletion/imbalance analysis of low-grade and atypical meningiomas. Nagasaka T; Gunji M; Hosokai N; Hayashi K; Fujino M; Ikeda H; Ito M; Inao S Neurol Med Chir (Tokyo); 2010 Jan; 50(1):27-32; discussion 32. PubMed ID: 20098021 [TBL] [Abstract][Full Text] [Related]
60. [Meningiomas and their cytogenetic implication]. Portero JA; García Quesada L; Rey JA; Ayuso C Rev Clin Esp; 1980 Jul; 157(5):305-8. PubMed ID: 7403603 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]